Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR

Rajneesh Nath, MD, Zheng Zhou, MD PhD, Jan Cerny, MD PhD, Hai-Lin Wang, MPH, Khalid Bo-Subait, Zartash Guth, Gulrayz Ahmed, Muhammad Wagas Khan, Gerhard Carl Hildebrandt, MD, Hassan B. Alkhateeb, MD, Moussab Damlaj, MD, Mrinal M. Patnaik, MD MBBS, Brenda M. Sandmaier, MD, Daniel J. Weisdorf, MD, Marcos de Lima, MD, Mark R. Litzow, MD, Wael Saber, MD MS

Blood (2018) 132 (Supplement 1): 3456.

https://doi.org/10.1182/blood-2018-99-116795

Published: 2018

Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC

Blood (2017) 130 (Supplement 1): 2799.

https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799

Published: 2017

Journal Articles

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Mohsen Al-Zahrani, MD, Ahmed Alaskar, MD FRCPC, Moussab Damlaj, MD, Khadega Abuelgasim, MD, Giamal Gmati, MD, Hind ABDIN Salama, MD, Samer Ghazi, Osama Ali, MD, Bader Alahmari, MD, Ayman Hejazi, MD

Blood (2017) 130 (Supplement 1): 5549.

https://doi.org/10.1182/blood.V130.Suppl_1.5549.5549

Published: 2017

Journal Articles

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Moussab Damlaj, MD, Ghazi Samer, Giamal Edin Mohamed Gmati, MD, Walid Mashaqbeh, Mohsen Al Zahrani, MD, Khadega Ahmed Abuelgasim, MD, Mushtaq Rather, MD, Hend Salama, MD, Ahmed Askar, MD, Ayman Hejazi, MD

Blood (2016) 128 (22): 5787.

https://doi.org/10.1182/blood.V128.22.5787.5787

Published: 2016

Journal Articles

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Fevzi Yalniz, MD, Mehrdad Hefazi, MD, Kristen B. McCullough, PharmD, Mark Litzow, MD, William J Hogan, MBChB, Robert C Wolf, PharmD, Hassan B Alkhateeb, MD, Ankit Kansagra, Moussab Damlaj, MD, Mrinal M Patnaik, MBBS

Blood (2016) 128 (22): 4593.

https://doi.org/10.1182/blood.V128.22.4593.4593

Published: 2016

Journal Articles

Role of FDG-PET/CT for Detection of Occult Bone Marrow Involvement in Patients from the Middle East and North Africa Region with Hodgkin Lymphoma

Moussab Damlaj, MD, Giamal Edin Mohamed Gmati, MD, Ghulam Syed, MD, Mohsen Al Zahrani, MD, Khadega Ahmed Abuelgasim, MD, Mushtaq Rather, MD, Salama Hend, MD, Hejazi Ayman, MD, Abdul-Rahman Jazieh, MD, Ahmed Askar, MD

Blood (2016) 128 (22): 5348.

https://doi.org/10.1182/blood.V128.22.5348.5348

Published: 2016

Journal Articles

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Daniel K. Partain, MD, Jehad Almasri, MD, Mehrdad Hefazi, MD, Shahrukh K. Hashmi, MD, Dennis A. Gastineau, MD, Aref Al-Kali, MD, Robert C Wolf, PharmD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 736.

https://doi.org/10.1182/blood.V126.23.736.736

Published: 2015

Journal Articles

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

Daniel K. Partain, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Shahrukh K. Hashmi, MD, Wilson I. Gonsalves, MD, James M. Foran, MD, Vivek Roy, MD FACP, Ruben A. Mesa, Jeanne Palmer, MD, James L. Slack, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4370.

https://doi.org/10.1182/blood.V126.23.4370.4370

Published: 2015

Journal Articles

Comparative Analysis of Azacitidine and Decitabine in Myelodysplastic Syndromes: A Systematic Review and Network Meta-Analysis

Jehad Almasri, MD, Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Zhen Wang, PhD, M. Hassan Murad, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 1692.

https://doi.org/10.1182/blood.V126.23.1692.1692

Published: 2015

Journal Articles

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Mehrdad Hefazi Torghabeh, MD, Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Raymund Razonable, MD, Aref Al-Kali, MD, Shahrukh K. Hashmi, MD, William J Hogan, MD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 1913.

https://doi.org/10.1182/blood.V126.23.1913.1913

Published: 2015

Journal Articles

Prognostic Impact of Peripheral Blood Count Recovery and Cytogenetic Remission Prior to Reduced Intensity Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndromes

Moussab Damlaj, MD, Hassan B Alkhateeb, MD, Mehrdad Hefazi, MD, Daniel K. Partain, MD, Aref Al-Kali, MD, Shahrukh K. Hashmi, MD, Naseema Gangat, MBBS, Mark R Litzow, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 3210.

https://doi.org/10.1182/blood.V126.23.3210.3210

Published: 2015

Journal Articles

The Adverse Impact of Age and Central Nervous System Involvement on Survival in Adult T-ALL, an Analysis of 92 Consecutive Patients

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Tasha Lin, MD, Mehrdad Hefazi, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, William J. Hogan, MBChB, Michelle Elliott, MD, Grzegorz S. Nowakowski, MD, Carrie Thompson, MD, Thomas E. Witzig, MD, Stephen M Ansell, MD, PhD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4993.

https://doi.org/10.1182/blood.V126.23.4993.4993

Published: 2015

Journal Articles

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Tasha Lin, MD, Aref Al-Kali, MD, Lisa Sproat, MD MSW, Jeffrey Alan Betcher, BSPharm, RPh, Jason N. Barreto, PharmD, Shahrukh K. Hashmi, MD, Mrinal M Patnaik, MBBS, Naseema Gangat, MBBS, Michelle Elliott, MD, Mark R Litzow, MD, William J Hogan, MBChB

Blood (2015) 126 (23): 4910.

https://doi.org/10.1182/blood.V126.23.4910.4910

Published: 2015

Journal Articles

Response to Hypomethylating Agents in Myelodysplastic Syndromes Based on WHO 2008 Subtypes and IPSS-R Stratification and Impact on Survival

Hassan B Alkhateeb, MD, Muhanad Hreh, Moussab Damlaj, MD, Michelle Elliott, MD, William J Hogan, MBChB, Mrinal M Patnaik, MBBS, Mark R Litzow, MD, Aref Al-Kali, MD

Blood (2015) 126 (23): 5260.

https://doi.org/10.1182/blood.V126.23.5260.5260

Published: 2015

Journal Articles

Clinical Characteristics and Outcome of Adult Acute Erythroleukemia; Mayo Clinic Experience

Hassan B Alkhateeb, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, William J Hogan, MBChB, Michelle Elliott, MD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 4980.

https://doi.org/10.1182/blood.V126.23.4980.4980

Published: 2015

Journal Articles

Survival Trends in Adult T-Acute Lymphoblastic Leukemia / Lymphoma (ALL), a Comparative Analysis of 92 Patients By Year of Diagnosis

Hassan B Alkhateeb, MD, Tasha Lin, MD, Moussab Damlaj, MD, Aref Al-Kali, MD, Naseema Gangat, MBBS, William J Hogan, MBChB, Michelle Elliott, MD, Grzegorz S. Nowakowski, MD, Carrie Thompson, MD, Thomas E. Witzig, MD, Stephen M Ansell, MD, PhD, Mark R Litzow, MD, Mrinal M Patnaik, MBBS

Blood (2015) 126 (23): 2490.

https://doi.org/10.1182/blood.V126.23.2490.2490

Published: 2015

NARROW

Reduced Intensity Conditioning (RIC) Regimens Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML): A Comparison of Fludarabine/Busulfan (FB) and Fludarabine/Melphalan (FM) Based Regimens from the CIBMTR

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Non-Myeloablative Transplant in Severe Sickle Cell Disease Is Safe & Effective. Single Center Experience from Saudi Arabia

Prognostic Impact of Blood Count Recovery Based Complete Remission Prior to Allogeneic Transplantation in Patients with Acute Leukemia

Clinical Outcomes Related to the Use of Monoclonal Antibody Therapy for Steroid Refractory Acute Graft-Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation

Role of FDG-PET/CT for Detection of Occult Bone Marrow Involvement in Patients from the Middle East and North Africa Region with Hodgkin Lymphoma

Fludarabine Busulfan Compared to Fludarabine Melphalan Is Associated with Increased Relapse Risk in Reduced Intensity Conditioning Transplant Despite Pharmacokinetic Dosing

The Role of Spleen Directed Therapy and Predictors of Outcomes with Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Primary Myelofibrosis and Splenomegaly

Comparative Analysis of Azacitidine and Decitabine in Myelodysplastic Syndromes: A Systematic Review and Network Meta-Analysis

Early CMV Infection Detected By Quantitative Nucleic Acid Testing (QNAT) Is Associated with Lower Risk of Relapse after Reduced Intensity, but Not Myeloablative, Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Prognostic Impact of Peripheral Blood Count Recovery and Cytogenetic Remission Prior to Reduced Intensity Allogeneic Transplantation in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndromes

The Adverse Impact of Age and Central Nervous System Involvement on Survival in Adult T-ALL, an Analysis of 92 Consecutive Patients

Clofarabine Based Chemotherapy in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma-a Single Institution Experience

Response to Hypomethylating Agents in Myelodysplastic Syndromes Based on WHO 2008 Subtypes and IPSS-R Stratification and Impact on Survival

Clinical Characteristics and Outcome of Adult Acute Erythroleukemia; Mayo Clinic Experience

Survival Trends in Adult T-Acute Lymphoblastic Leukemia / Lymphoma (ALL), a Comparative Analysis of 92 Patients By Year of Diagnosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only